{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:24:07Z","timestamp":1783700647810,"version":"3.55.0"},"publisher-location":"Chichester, UK","reference-count":56,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd001820.pub2","type":"reference-entry","created":{"date-parts":[[2006,5,9]],"date-time":"2006-05-09T20:10:34Z","timestamp":1147205434000},"source":"Crossref","is-referenced-by-count":13,"title":["Dipyridamole for preventing stroke and other vascular events in patients with vascular disease"],"prefix":"10.1002","author":[{"given":"ELLM","family":"De Schryver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Algra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"van Gijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,4,19]]},"reference":[{"key":"10.1002\/14651858.CD001820.pub2-BIB2|cit1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/01.STR.14.1.99","article-title":"Persantine aspirin trial in cerebral ischemia","volume":"14","year":"1983","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD001820.pub2-BIB1|cit2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/01.STR.16.3.406","article-title":"Persantine aspirin trial in cerebral ischemia. Part II: Endpoint results","volume":"16","year":"1985","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD001820.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.STR.14.1.5","article-title":"\"AICLA\" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia","volume":"14","author":"Bousser","year":"1983","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD001820.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/01.STR.14.1.5","article-title":"\"AICLA\" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia","volume":"14","author":"Bousser","year":"1983","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD001820.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/jama.1967.03130110091023","article-title":"Dipyridamole in the treatment of angina pectoris. A double-blind evaluation","volume":"201","author":"Sbar","year":"1967","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001820.pub2-BIB6|cit6","first-page":"88","article-title":"Angina Pectoris: a double blind study with dipyridamole","volume":"18","author":"Becker","year":"1967","journal-title":"Journal of the Newark Beth Israel Hospital"},{"key":"10.1002\/14651858.CD001820.pub2-BIB7|cit7","first-page":"1933","article-title":"Ischemic cerebrovascular disease: treatment with various anti-platelet aggregation drugs. Clinical follow-up of 80 patients (22-34 months)","volume":"76","author":"Caneschi","year":"1985","journal-title":"Minverva Medica"},{"key":"10.1002\/14651858.CD001820.pub2-BIB8|cit8","first-page":"1933","article-title":"Ischemic cerebrovascular disease: treatment with various anti-platelet aggregation drugs. Clinical follow-up of 80 patients (22-34 months)","volume":"76","author":"Caneschi","year":"1985","journal-title":"Minverva Medica"},{"key":"10.1002\/14651858.CD001820.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diab.38.4.491","article-title":"Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial","volume":"38","year":"1989","journal-title":"Diabetes"},{"key":"10.1002\/14651858.CD001820.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diab.38.4.491","article-title":"Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial","volume":"38","year":"1989","journal-title":"Diabetes"},{"key":"10.1002\/14651858.CD001820.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/01.STR.21.8.1122","article-title":"European Stroke Prevention Study","volume":"21","year":"1990","journal-title":"Stroke"},{"key":"10.1002\/14651858.CD001820.pub2-BIB13|cit12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD001820.pub2-BIB12|cit13","first-page":"S1","article-title":"European Stroke Prevention Study 2. Efficacy and safety data","volume":"151(suppl)","year":"1997","journal-title":"Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD001820.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD001820.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD001820.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD001820.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/bmj.4.5627.366","article-title":"Dipyridamole: a controlled trial of its effect in acute myocardial infarction","volume":"4","author":"Gent","year":"1968","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001820.pub2-BIB18|cit18","unstructured":"The profylaxis of thrombosis in new arteriovenous dialysis shunts in the arm by low-dose acetylsalicylic acid and dipyridamole Unpublished work 1992"},{"key":"10.1002\/14651858.CD001820.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0140-6736(85)91144-4","article-title":"Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. A prospective double-blind arteriographically controlled trial","volume":"1","author":"Hess","year":"1985","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001820.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0140-6736(85)91144-4","article-title":"Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. A prospective double-blind arteriographically controlled trial","volume":"1","author":"Hess","year":"1985","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001820.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1532-5415.1970.tb02124.x","article-title":"Treatment of angina pectoris with dipyridamole: a double-blind study","volume":"18","author":"Igloe","year":"1970","journal-title":"Journal of the American Geriatric Society"},{"key":"10.1002\/14651858.CD001820.pub2-BIB23|cit22","first-page":"321","article-title":"Dipyridamole combined with acetylsalicylic acid versus acetylsalicylic acid alone in the treatment of peripheral vascular disease","volume":"3","author":"Catalano","year":"1984","journal-title":"International Angiology"},{"key":"10.1002\/14651858.CD001820.pub2-BIB22|cit23","first-page":"207","article-title":"Treatment of claudication with dipyridamole and aspirin","volume":"14","author":"Libretti","year":"1986","journal-title":"Monographs on Atherosclerosis"},{"key":"10.1002\/14651858.CD001820.pub2-BIB24|cit24","first-page":"266","article-title":"Antiplatelet therapy in coronary disease progression reduced infarction and new lesion formation","volume":"80 (suppl II)","author":"Chesebro","year":"1989","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD001820.pub2-BIB25|cit25","first-page":"558","article-title":"Comparative trials of sulphinpyrazone and aspirin + dipyridamole in acute myocardial infarction","volume":"34","author":"Misra","year":"1983","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD001820.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0735-1097(86)80489-2","article-title":"Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin","volume":"7","author":"Klimt","year":"1986","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD001820.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1161\/01.CIR.62.3.449","article-title":"The Persantine-Aspirin reinfarction study","volume":"62","year":"1980","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD001820.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1161\/01.CIR.62.3.449","article-title":"The Persantine-Aspirin reinfarction study","volume":"62","year":"1980","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD001820.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1053\/euhj.2001.2623","article-title":"Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study","volume":"22","author":"Picano","year":"2001","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD001820.pub2-BIB30|cit30","first-page":"267","article-title":"Treatment of unstable angina with dipyridamole combined with low doses of aspirin. A multicenter pilot double-blind controlled study","volume":"39","author":"Prandoni","year":"1991","journal-title":"Minerva Cardioangiologica"},{"key":"10.1002\/14651858.CD001820.pub2-BIB31|cit31","series-title":"Proceedings of X World Congress of Cardiology. Washington","first-page":"302 (Abstract 1","article-title":"Efficacy of platelet-inhibiting agents in the prevention of reinfarction in smoker patients","author":"Gentile","year":"1986"},{"key":"10.1002\/14651858.CD001820.pub2-BIB34|cit32","first-page":"429","article-title":"Long-term results with conservative treatment of occlusive arteriopathies","volume":"25","author":"Schoop","year":"1984","journal-title":"Internist"},{"key":"10.1002\/14651858.CD001820.pub2-BIB33|cit33","first-page":"49","article-title":"Experimentelle und klinische Studien zu der sekund\u00e4ren Pr\u00e4vention der peripheren Arteriosklerose","volume-title":"Thrombozytenfunktionshemmer, Wirkungsmechanismen, Dosierung und praktische Anwendung","author":"Schoop","year":"1983"},{"key":"10.1002\/14651858.CD001820.pub2-BIB32|cit34","first-page":"137","article-title":"Prevention of peripheral arterial occlusive disease with antiaggregants","volume":"50","author":"Schoop","year":"1983","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD001820.pub2-BIB35|cit35","first-page":"49","volume-title":"Thrombozytenfunktionshemmer, Wirkungsmechanismen, Dosierung und praktische Anwendung","author":"Schoop","year":"1983"},{"key":"10.1002\/14651858.CD001820.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/ki.1994.192","article-title":"Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study","volume":"45","author":"Sreedhara","year":"1994","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD001820.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/ki.1994.192","article-title":"Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study","volume":"45","author":"Sreedhara","year":"1994","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD001820.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/ki.1994.192","article-title":"Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study","volume":"45","author":"Sreedhara","year":"1994","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD001820.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/ki.1994.192","article-title":"Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study","volume":"45","author":"Sreedhara","year":"1994","journal-title":"Kidney International"},{"key":"10.1002\/14651858.CD001820.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1136\/bmj.1.5644.614","article-title":"Controlled trial of dipyridamole in cerebral vascular disease","volume":"i","author":"Acheson","year":"1969","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001820.pub2-BIB41|cit41","first-page":"367","volume":"138","author":"Guiraud-Chaumeil","year":"1982","journal-title":"Revue Neurologique (Paris)"},{"key":"10.1002\/14651858.CD001820.pub2-BIB42|cit42","first-page":"367","volume":"138","author":"Guiraud-Chaumeil","year":"1982","journal-title":"Revue Neurologique (Paris)"},{"key":"10.1002\/14651858.CD001820.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/diacare.9.2.140","article-title":"Veterans Administration Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: II. Effects of aspirin and dipyridamole on atherosclerotic vascular disease rates","volume":"9","author":"Colwell","year":"1986","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD001820.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0735-1097(94)00331-J","article-title":"Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy","volume":"25","author":"White","year":"1995","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD001820.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0021-9681(67)90048-3","article-title":"Treatment of angina pectoris with dipyridamole: a long-term double blind study","volume":"20","author":"Wirecki","year":"1967","journal-title":"Journal of Chronic Diseases"},{"issue":"2","key":"10.1002\/14651858.CD001820.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000016044","article-title":"Design of ESPRIT: an international randomized trial for secondary prevention after non-disabling cerebral ischaemia of arterial origin. European\/Australian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT) group","volume":"10","author":"Schryver","year":"2000","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD001820.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/jnnp.60.2.197","article-title":"Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia","volume":"60","author":"Algra","year":"1996","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD001820.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/jnnp.66.5.557","article-title":"Secondary prevention after cerebral ischaemia of presumed arterial origin: is aspirin still the touchstone?","volume":"66","author":"Algra","year":"1999","journal-title":"Journal of Neurology Neurosurgery abd Psychiatry"},{"key":"10.1002\/14651858.CD001820.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/jnnp.66.2.255","article-title":"Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin","volume":"66","author":"Algra","year":"1999","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD001820.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy - 1: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001820.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001820.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJM199110313251801","article-title":"A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke","volume":"325","year":"1991","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001820.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1056\/NEJM198705143162005","article-title":"Modern drug therapy: dipyridamole","volume":"316","author":"FitzGerald","year":"1987","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001820.pub2-BIB54|cit54","unstructured":"Kaye J A trial to evaluate the relative roles of dipyridamole and aspirin in the prevention of deep vein thrombosis in stroke patients Boehringer Ingelheim internal report 1990"},{"key":"10.1002\/14651858.CD001820.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/jnnp.54.12.1044","article-title":"The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results","volume":"54","year":"1991","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD001820.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/0140-6736(92)90608-6","article-title":"Secondary prevention of stroke","volume":"339","author":"Warlow","year":"1992","journal-title":"Lancet"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001820.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2007,7,18]],"date-time":"2007-07-18T00:00:00Z","timestamp":1184716800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001820.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:05:44Z","timestamp":1628543144000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001820.pub2"}},"subtitle":[],"editor":[{"given":"Ale","family":"Algra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2006,4,19]]},"references-count":56,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001820.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD001820.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2006,4,19]]}}}